{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Natural Product[C66892]|Plant-based Natural Product[C106104]|Plant Part[C79611]" in comments (approximate match)
Status:
Possibly Marketed Outside US
Source:
Salicylic Acid by Bejing Rimeng Biological Technology Co Ltd
(2009)
Source URL:
First approved in 1989
Source:
21 CFR 334
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT00554268: Phase 1 Interventional Completed Solid Tumors
(2007)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04157530: Not Applicable Interventional Completed Glaucoma
(2018)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE